6-Phenylbenzo[d]thiazol-2-amine

Catalog No.: 
ACGFBX207
CAS No.: 
73458-38-5
Molecular Formula: 
C13H10N2S
Molecular Weight: 
226.30
6-Phenylbenzo[d]thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%
250mg95%
1g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Phenylbenzo[d]thiazol-2-amine
IUPAC Name6-phenylbenzo[d]thiazol-2-amine
MDL No.MFCD00447622
Molecular FormulaC13H10N2S
Molecular Weight226.30
SMILESNC1=NC2=C(S1)C=C(C=C2)C1=CC=CC=C1
InChI KeyGIOCFNWQTZDWNE-UHFFFAOYSA-N
Synonym6-Phenylbenzo[d]thiazol-2-aMine;2-Benzothiazolamine, 6-phenyl-;6-Phenylbenzo[d]thiazol-2(3h)-imine
CAS No.73458-38-5
PubChem CID5109813

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACGFBX207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACGFBX207 route product structure diagram
    ACGFBX20773458-38-5In Stock
Inquiry

2. ACGFBX207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHOEF421 route compound structure diagram
    ACHOEF42116582-58-4In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACGFBX207 route product structure diagram
    ACGFBX20773458-38-5In Stock
Inquiry

3. ACGFBX207 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACGFBX207 route product structure diagram
    ACGFBX20773458-38-5In Stock
Inquiry

Comments (0)